New mRNA technology could strengthen the immune system of older adults

A groundbreaking scientific discovery could change the way we approach the ageing of the immune system. Researchers at the Massachusetts Institute of Technology (MIT) and the Broad Institute have developed an innovative technique that uses messenger RNA to help older organisms strengthen their natural defences against disease.

As people age, the production of T-lymphocytes — the cells that play a crucial role in fighting infections and disease — declines considerably. This reduction makes older people more vulnerable to illness and less responsive to vaccines, a problem affecting millions of seniors worldwide.

The innovative solution developed by the researchers is based on temporarily reprogramming the liver to take over the function of the thymus, the organ responsible for producing T-lymphocytes, which naturally atrophies with age. By injecting messenger RNA, the liver is "instructed" to produce three biological factors essential for the development and optimal functioning of these immune cells.

The results from animal model testing have been encouraging. Older mice treated with this technique demonstrated a significant improvement in immune function: they produced more active T-cells, responded more effectively to vaccination, and reacted better to cancer therapies.

This approach could offer hope for improving the quality of life of older people, providing better protection against infections and other conditions associated with ageing. However, the researchers emphasise that the technology is still at an experimental stage and requires extensive further study before it can be applied in humans.

The next step involves testing the method on other animal models to assess long-term safety and to refine the technique with a view to eventual clinical use. If proven safe and effective, this innovation could revolutionise the medical care of elderly people and contribute to healthier ageing.